Senior Congress chief Manish Tewari immediately raised questions over the emergency use approval granted to the indigenously developed Covaxin and alleged that it was “sans due course of”. His remarks come on a day India launched one of many world’s largest vaccination drives in opposition to the lethal coronavirus.
India lately granted approval for restricted emergency use to 2 vaccines, Oxford-AstraZeneca’s Covishield, manufactured by the Serum Institute of India, and Bharat Biotech’s Covaxin.
“As vaccine roll out begins, it’s all a bit puzzling. India has no coverage framework for authorising emergency use. But, two vaccines have been permitted for restricted use in emergency state of affairs,” Mr Tewari mentioned in a tweet simply earlier than Prime Minister Narendra Modi launched the vaccination drive.
“COVAXIN is one other story — Approvals sans Due Course of,” the previous Union minister added, tagging a media report which claimed scientists and medical doctors are divided on the problem of restricted use approval granted to the Hyderabad-based Bharat Biotech’s Covaxin.
Earlier, senior Congress leaders Anand Sharma, Jairam Ramesh and Shashi Tharoor had additionally raised issues over India’s medicine regulator’s nod to restricted use of Bharat Biotech’s COVID-19 vaccine.
Nonetheless, there have been completely different voices throughout the social gathering as its chief spokesperson Randeep Surjewala had lauded scientists and researchers of Bharat Biotech for the indigenous vaccine.
The BJP, in response, to the criticism by some Congress leaders had hit out at them with social gathering president JP Nadda alleging that each time India achieves one thing commendable the opposition social gathering comes up with “wild theories” to “ridicule” the accomplishments.
(This story has not been edited by NDTV employees and is auto-generated from a syndicated feed.)